Cargando…
Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
Autores principales: | Billioti de Gage, Sophie, Drouin, Jérôme, Desplas, David, Cuenot, François, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747036/ https://www.ncbi.nlm.nih.gov/pubmed/33331873 http://dx.doi.org/10.1001/jamaophthalmol.2020.5594 |
Ejemplares similares
-
Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023) -
Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
por: Roland, Noémie, et al.
Publicado: (2021) -
Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
por: Roland, Noémie, et al.
Publicado: (2022) -
Roll-out of HIV pre-exposure prophylaxis use in France: A nationwide observational study from 2016 to 2021
por: Billioti de Gage, Sophie, et al.
Publicado: (2022) -
Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)